{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T23:46:33Z","timestamp":1792453593252,"version":"4.5.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2006,8,1]],"date-time":"2006-08-01T00:00:00Z","timestamp":1154390400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,8,1]],"date-time":"2006-08-01T00:00:00Z","timestamp":1154390400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2006,8,1]],"date-time":"2006-08-01T00:00:00Z","timestamp":1154390400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2006,8,1]],"date-time":"2006-08-01T00:00:00Z","timestamp":1154390400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2006,8,1]],"date-time":"2006-08-01T00:00:00Z","timestamp":1154390400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2006,8,1]],"date-time":"2006-08-01T00:00:00Z","timestamp":1154390400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2006,8,1]],"date-time":"2006-08-01T00:00:00Z","timestamp":1154390400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","goldjournal.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urology"],"published-print":{"date-parts":[[2006,8]]},"DOI":"10.1016\/j.urology.2006.02.042","type":"journal-article","created":{"date-parts":[[2006,8,12]],"date-time":"2006-08-12T07:09:01Z","timestamp":1155366541000},"page":"318-323","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":695,"title":["Symptom assessment tool for overactive bladder syndrome\u2014overactive bladder symptom score"],"prefix":"10.1016","volume":"68","author":[{"given":"Yukio","family":"Homma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaki","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narihito","family":"Seki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osamu","family":"Yokoyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidehiro","family":"Kakizaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Momokazu","family":"Gotoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomonori","family":"Yamanishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osamu","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Takeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osamu","family":"Nishizawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.urology.2006.02.042_bib1","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/nau.10052","article-title":"The standardisation of terminology of lower urinary tract function","volume":"21","author":"Abrams","year":"2002","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.urology.2006.02.042_bib2","first-page":"S580","article-title":"Overactive bladder significantly affects quality of life","volume":"6","author":"Abrams","year":"2000","journal-title":"Am J Manag Care"},{"key":"10.1016\/j.urology.2006.02.042_bib3","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1023\/A:1016370925601","article-title":"Psychometric validation of an overactive bladder symptom and health-related quality of life questionnaire","volume":"11","author":"Coyne","year":"2002","journal-title":"Qual Life Res"},{"key":"10.1016\/j.urology.2006.02.042_bib4","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s00345-004-0455-3","article-title":"Health-related quality of life of Japanese patients with overactive bladder treated with extended-release tolterodine or immediate-release oxybutynin","volume":"22","author":"Homma","year":"2004","journal-title":"World J Urol"},{"key":"10.1016\/j.urology.2006.02.042_bib5","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0090-4295(02)01784-3","article-title":"Definition and epidemiology of overactive bladder","volume":"60","author":"Wein","year":"2002","journal-title":"Urology"},{"key":"10.1016\/j.urology.2006.02.042_bib6","first-page":"266","article-title":"Epidemiologic survey on lower urinary tract symptoms in Japan","volume":"14","author":"Homma","year":"2003","journal-title":"J Neurogen Bladder Soc"},{"key":"10.1016\/j.urology.2006.02.042_bib7","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1016\/S0022-5347(05)64261-9","article-title":"Current and future pharmacological treatment for overactive bladder","volume":"168","author":"Yoshimura","year":"2002","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2006.02.042_bib8","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/nau.20110","article-title":"Test-retest reliability of four questionnaires for patients with overactive bladder","volume":"24","author":"Matza","year":"2005","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.urology.2006.02.042_bib9","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1007\/s11136-004-0706-1","article-title":"The responsiveness of the Overactive Bladder Questionnaire (OAB-q)","volume":"14","author":"Coyne","year":"2005","journal-title":"Qual Life Res"},{"key":"10.1016\/j.urology.2006.02.042_bib10","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1097\/01.ju.0000165461.38088.7b","article-title":"A validated patient reported measure of urinary urgency severity in overactive bladder for use in clinical trials","volume":"174","author":"Nixon","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2006.02.042_bib11","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1097\/01.ju.0000154692.73129.d8","article-title":"The Overactive Bladder-Symptom Composite Score","volume":"173","author":"Zinner","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2006.02.042_bib12","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1002\/nau.20041","article-title":"ICIQ","volume":"23","author":"Avery","year":"2004","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.urology.2006.02.042_bib13","first-page":"248","article-title":"Development of symptom questionnaire for urinary incontinence (2)\u2014validation of questionnare","volume":"14","author":"Homma","year":"2003","journal-title":"J Neurogen Bladder Soc"},{"key":"10.1016\/j.urology.2006.02.042_bib14","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1111\/j.1471-0528.1997.tb11006.x","article-title":"A new questionnaire to assess the quality of life of urinary incontinent women","volume":"104","author":"Kelleher","year":"1997","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.urology.2006.02.042_bib15","first-page":"225","article-title":"Development of Japanese version of QOL questionnaires for urinary incontinence","volume":"10","author":"Homma","year":"1999","journal-title":"J Neurogen Bladder Soc"},{"key":"10.1016\/j.urology.2006.02.042_bib16","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1002\/nau.10169","article-title":"Reliability and validity of King\u2019s Health Questionnaire in patients with symptoms of overactive bladder with urge incontinence in Japan","volume":"23","author":"Uemura","year":"2004","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.urology.2006.02.042_bib17","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1442-2042.1997.tb00138.x","article-title":"Epidemiologic survey of lower urinary tract symptoms in Asia and Australia using the International Prostate Symptom Score","volume":"4","author":"Homma","year":"1997","journal-title":"Int J Urol"},{"key":"10.1016\/j.urology.2006.02.042_bib18","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1111\/j.1464-410X.2005.05454.x","article-title":"A pooled analysis of three phase III studies to investigate the efficacy, tolerability and safety of darifenacin, a muscarinic M3 selective receptor antagonist, in the treatment of overactive bladder","volume":"95","author":"Chapple","year":"2005","journal-title":"BJU Int"},{"key":"10.1016\/j.urology.2006.02.042_bib19","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1016\/S0022-5347(17)36966-5","article-title":"The American Urological Association symptom index for benign prostatic hyperplasia","volume":"148","author":"Barry","year":"1992","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2006.02.042_bib20","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/BF00451721","article-title":"Health-related quality of life measures for women with urinary incontinence","volume":"3","author":"Shumaker","year":"1994","journal-title":"Qual Life Res"},{"key":"10.1016\/j.urology.2006.02.042_bib21","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0090-4295(99)80384-7","article-title":"Quality of life of persons with urinary incontinence","volume":"47","author":"Wagner","year":"1996","journal-title":"Urology"},{"key":"10.1016\/j.urology.2006.02.042_bib22","first-page":"560","article-title":"[Evaluation of psychometric properties of Japanese version of international prostate symptom score and BPH impact index]","volume":"94","author":"Homma","year":"2003","journal-title":"Nippon Hinyokika Gakkai Zasshi"}],"container-title":["Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429506007400?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429506007400?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T01:44:05Z","timestamp":1758764645000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090429506007400"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,8]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,8]]}},"alternative-id":["S0090429506007400"],"URL":"https:\/\/doi.org\/10.1016\/j.urology.2006.02.042","relation":{},"ISSN":["0090-4295"],"issn-type":[{"value":"0090-4295","type":"print"}],"subject":[],"published":{"date-parts":[[2006,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Symptom assessment tool for overactive bladder syndrome\u2014overactive bladder symptom score","name":"articletitle","label":"Article Title"},{"value":"Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urology.2006.02.042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}